- UnitedHealth stock came under pressure in 2025, losing about 35% of its value
- Primary pressure points included overutilization of medical services by senior citizens and a Federal investigation
- Most analysts see 2026 as a transition year for UNH, but the majority still have a "moderate buy" rating on it
UnitedHealth Group stock (NYSE: UNH) has shown promising upside in early 2026, gaining about 6.5% year-to-date, trading around $351 as of this writing. This follows a challenging 2025, where shares tumbled 35% amid elevated medical costs in Medicare Advantage.
Is This the Beginning of a Stronger Reversal?
These early gains hint at a possible comeback. Some analysts see 2026 as a year of recovery. Most of the bad news from last year seems to be accounted for in the current stock price, and such a scenario could set UnitedHealth up for gains.
Zacks Investment Research notes that the industry is starting to adjust prices, with insurers like UnitedHealth raising their premiums to match last year’s higher medical service use. If UnitedHealth performs as expected, the stock could keep rising and make up for 2025’s losses. The company’s management has settled on a 5.06% increase in payments for Medicare Advantage plans for 2026 and that could create some stability.
UNH Stock Pivotal Fundamentals
Strong earnings from Optum and Medicare will be key to the stock’s recovery. The 5.06% payment increase for Medicare Advantage plans in 2026 should provide some needed relief for tight profit margins.
Optum is still a major strength for the company and should help lower overall medical costs in 2026 by improving efficiency. If medical costs stabilize and enrollment increases, the company’s performance could improve throughout the year.
Potential Risks Ahead
There are still risks to consider, despite the recent hints of recovery. UnitedHealth has a Moderate Buy rating, not a Strong Buy, because of ongoing challenges. Forbes points out three reasons why the stock might not be appealing, including the risk of sharp drops from unexpected events.
The company also plans to voluntarily refund some Affordable Care Act (ACA) profits this year. This is meant to ease political pressure but will limit certain profit margins. The Department of Justice’s review of the managed care industry also remains a concern for investors.
UNH Stock Price Prediction
UnitedHealth stock is trading near $351 and seems to be holding steady. The RSI is at 59, which means the buyers currently have the upper hand. The stock has moved above its 10,50,100 and 200-day Simple Moving Averages (SMAs). The first resistance will likely be at $356.20, with an extended bullishness potentially taking the stock to $360. On the lower side, the primary support will likely be at the 10-day SMA at $342.79, below which the upside narrative will be invalid, with the momentum potentially setting up the second support at $335.20.
UNH stock daily chart with key support and resistance levels on January 27, 2026. Created on TradingView
Potentially yes. The bad news from last year seems to be priced in, and there’s some early positive momentum. However, sustained earnings growth is needed to make up for the 35% losses.
Higher-than-expected use of medical services by seniors put a strain on Medicare Advantage profits. This, along with changes in leadership and regulatory investigations, hurt the stock price.
Potential risks include regulatory reviews, policy changes, ACA impacts, unexpected increases in medical costs, and sharp drops from external events.